BenevolentAI appoints New Chief Technology Officer

BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, today announces that the current Chief Technology Officer (CTO), Dr. Daniel Neil, is leaving the Company at the beginning of April after 7 years at BenevolentAI to relocate to be nearer...

The post BenevolentAI appoints New Chief Technology Officer first appeared on AI-TechPark.

advanced advanced ai ai april biopharma chief technology officer cto current daniel discovery drug discovery leader neil technology the company